Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.verified

RLMD

Price:

$0.3614

Market Cap:

$10.90M

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.[Read more]

Industry

Biotechnology

IPO Date

2014-06-20

Stock Exchange

NASDAQ

Ticker

RLMD

The Dividend Yield as of December 2024 (TTM) for Relmada Therapeutics, Inc. (RLMD) is 0%

According to Relmada Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Relmada Therapeutics, Inc. (RLMD) Historical Dividend Yield (quarterly & annually)

How has RLMD Dividend Yield performed in the past?

The mean historical Dividend Yield of Relmada Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RLMD's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Relmada Therapeutics, Inc. (RLMD) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Relmada Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%

Relmada Therapeutics, Inc. (RLMD) Average Dividend Yield

How has RLMD Dividend Yield performed in the past?

The current Dividend Yield of Relmada Therapeutics, Inc. (RLMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Relmada Therapeutics, Inc. (RLMD) Dividend Yield vs. Peers

How is RLMD’s Dividend Yield compared to its peers?

Relmada Therapeutics, Inc.’s Dividend Yield is less than Cytokinetics, Incorporated (0%), less than DICE Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Karuna Therapeutics, Inc. (0%), less than Dyne Therapeutics, Inc. (0%), less than Third Harmonic Bio, Inc. (0%), less than PMV Pharmaceuticals, Inc. (0%), less than Enochian Biosciences, Inc. (0%), less than Revolution Medicines, Inc. (0%), less than Pardes Biosciences, Inc. (0%), less than Shattuck Labs, Inc. (0%), less than Eliem Therapeutics, Inc. (0%), less than Champions Oncology, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Fusion Pharmaceuticals Inc. (0%), less than Bicycle Therapeutics plc (0%), less than RAPT Therapeutics, Inc. (0%), less than NewAmsterdam Pharma Company N.V. (0%), less than Cyteir Therapeutics, Inc. (0%), less than Nuvation Bio Inc. (0%), less than Magenta Therapeutics, Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%), less than Graphite Bio, Inc. (64.78%),

Build a custom stock screener for Relmada Therapeutics, Inc. (RLMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Relmada Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Relmada Therapeutics, Inc. (RLMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Relmada Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Relmada Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Relmada Therapeutics, Inc. (RLMD)?

What is the highest Dividend Yield for Relmada Therapeutics, Inc. (RLMD)?

What is the 3-year average Dividend Yield for Relmada Therapeutics, Inc. (RLMD)?

What is the 5-year average Dividend Yield for Relmada Therapeutics, Inc. (RLMD)?

How does the current Dividend Yield for Relmada Therapeutics, Inc. (RLMD) compare to its historical average?